Castleview Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,379
| Closed | -$208K | – | 436 |
|
|
2024
Q4 | $208K | Sell |
2,379
-171
| -7% | -$15K | 0.11% | 187 |
|
|
2024
Q3 | $304K | Buy |
2,550
+6
| +0.2% | +$714 | 0.18% | 138 |
|
|
2024
Q2 | $363K | Buy |
2,544
+99
| +4% | +$14.1K | 0.21% | 113 |
|
|
2024
Q1 | $314K | Buy |
2,445
+30
| +1% | +$3.85K | 0.18% | 132 |
|
|
2023
Q4 | $250K | Sell |
2,415
-24
| -1% | -$2.48K | 0.18% | 121 |
|
|
2023
Q3 | $222K | Buy |
+2,439
| New | +$222K | 0.21% | 104 |
|
|
2022
Q1 | – | Sell |
-20,832
| Closed | -$93 | – | 918 |
|
|
2021
Q4 | $93 | Buy |
+20,832
| New | +$93 | ﹤0.01% | 816 |
|